| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net income | ||||||
937,664 | 370,930 | 93,764 | 366,186 | -315,845 | ||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Depreciation and amortization | ||||||
193,356 | 239,998 | 264,742 | 264,879 | 282,946 | ||
Amortization of operating lease right-of-use assets | ||||||
122,673 | 0 | 0 | - | - | ||
Loss on impairment of assets | ||||||
43,754 | 13,110 | 40,597 | 23,465 | 0 | ||
Loss (gain) on sales of subsidiaries and disposal of property and equipment, net | ||||||
796,333 | 292,108 | 5,837 | 408,672 | 5,141 | ||
Gain on derivative instruments | ||||||
7,438 | 89,143 | 29,278 | - | - | ||
(Gain) loss on derivative instruments | ||||||
7,438 | 89,143 | 29,278 | -4,717 | -1,988 | ||
Payments for settlement of derivative contracts | ||||||
-8,772 | 14,117 | 0 | 0 | - | ||
Loss on debt extinguishment | ||||||
-28,752 | -7,481 | -8,392 | -17,363 | -331 | ||
Payment of redemption and call premiums and fees on debt modification | ||||||
- | - | - | - | 0 | ||
Non-cash interest expense | ||||||
3,535 | 15,408 | 49,582 | 46,195 | 55,786 | ||
Interest paid on deferred purchase price for acquisitions | ||||||
5,305 | 4,463 | 39,419 | 0 | 0 | ||
Non-cash share-based compensation expense | ||||||
12,994 | 10,791 | 64,788 | 38,809 | 39,021 | ||
Bad debt expense | ||||||
100,829 | 112,440 | 124,308 | 108,019 | 107,162 | ||
Deferred income taxes | ||||||
-29,813 | -7,474 | -164,785 | -30,150 | -15,563 | ||
Unrealized foreign currency exchange (gain) loss | ||||||
-29,186 | -37,796 | -4,135 | 67,946 | -124,487 | ||
Non-cash loss from non-income tax contingencies | ||||||
-9,075 | -6,839 | 2,883 | -17,360 | -182 | ||
Other, net | ||||||
5,341 | 10,297 | -3,463 | -5,949 | -2,583 | ||
Changes in operating assets and liabilities: | ||||||
Restricted cash | ||||||
- | - | - | - | 932 | ||
Receivables | ||||||
163,202 | 83,316 | 129,335 | 110,693 | 225,027 | ||
Prepaid expenses and other assets | ||||||
42,047 | 39,347 | 60,051 | 17,594 | 15,533 | ||
Accounts payable and accrued expenses | ||||||
5,574 | -7,512 | -30,407 | 688 | 15,237 | ||
Income tax receivable/payable, net | ||||||
-36,220 | 48,875 | -10,695 | -36,762 | 13,673 | ||
Deferred revenue and other liabilities | ||||||
-53,152 | 52,733 | 11,076 | -29,557 | 105,131 | ||
Net cash (used in) provided by operating activities | ||||||
339,769 | 396,858 | 192,157 | 192,256 | 170,486 | ||
Cash flows from investing activities | ||||||
Purchase of property and equipment | ||||||
155,641 | 238,046 | 274,063 | 240,258 | 344,056 | ||
Expenditures for deferred costs | ||||||
17,701 | 19,866 | 19,717 | 16,436 | 22,802 | ||
Receipts from sales of discontinued operations, net of cash sold, and property and equipment | ||||||
1,266,042 | 375,807 | 9,831 | 554,441 | 204,076 | ||
Settlement of derivatives related to sale of discontinued operations and net investment hedge | ||||||
-12,866 | 9,960 | 0 | - | - | ||
Settlement of derivatives related to sale of discontinued operations | ||||||
- | - | - | 5,663 | 0 | ||
Proceeds from property insurance recoveries and corporate-owned life insurance | ||||||
842 | 27,356 | 370 | 3,623 | 2,198 | ||
Business acquisitions, net of cash acquired | ||||||
1,205 | 17,019 | 835 | 0 | 6,705 | ||
Payment of contingent consideration for acquisitions | ||||||
- | - | - | - | 1,275 | ||
Payments from related parties | ||||||
84 | -2,778 | -268 | 1,590 | 8,896 | ||
Proceeds from sale of investment | ||||||
11,473 | 0 | 0 | - | 1,478 | ||
Change in restricted cash and investments | ||||||
- | - | - | - | 15,452 | ||
Net cash (used in) provided by investing activities | ||||||
1,116,760 | 115,494 | -284,682 | 297,297 | -173,642 | ||
Cash flows from financing activities | ||||||
Proceeds from issuance of long-term debt, net of original issue discount | ||||||
1,123,179 | 485,470 | 2,898,836 | 708,827 | 628,512 | ||
Payments on long-term debt | ||||||
2,507,790 | 867,915 | 3,038,946 | 1,421,379 | 528,025 | ||
Payments of deferred purchase price for acquisitions | ||||||
-20,157 | -13,650 | -94,891 | -22,236 | -25,582 | ||
Proceeds from issuance of convertible redeemable preferred stock, net of issuance costs | ||||||
0 | 0 | 55,290 | 329,142 | 0 | ||
Payment of dividends on Series A Preferred Stock and to noncontrolling interests | ||||||
0 | 11,103 | 19,371 | 1,505 | 20,472 | ||
Proceeds from initial public offering, net of issuance costs | ||||||
0 | 0 | 456,359 | 0 | 0 | ||
Proceeds from exercise of stock options | ||||||
14,007 | 0 | 0 | 253 | 2,040 | ||
Payments to repurchase common stock | ||||||
264,093 | 0 | 0 | - | - | ||
Withholding of shares to satisfy tax withholding for vested stock awards and exercised stock options | ||||||
2,245 | 2,528 | 2,151 | 1,725 | 3,868 | ||
Payments of debt issuance costs | ||||||
9,091 | 587 | 81,242 | 11,582 | 13,020 | ||
Payments to purchase noncontrolling interests | ||||||
5,761 | 127 | 17,443 | 25,665 | 5,351 | ||
Noncontrolling interest holder's loan to subsidiaries | ||||||
0 | 0 | 943 | 802 | 2,772 | ||
Distributions (to) from noncontrolling interest holders | ||||||
-2,026 | 311 | 186 | -654 | -2,582 | ||
Net cash provided by (used in) financing activities | ||||||
-1,673,977 | -410,129 | 157,570 | -445,722 | 34,424 | ||
Effects of exchange rate changes on Cash and cash equivalents and Restricted cash | ||||||
-7,338 | -13,481 | 25,906 | 3,478 | -22,407 | ||
Change in cash included in current assets held for sale | ||||||
167,764 | -30,915 | -32,983 | -3,492 | -37,658 | ||
Net change in Cash and cash equivalents and Restricted cash | ||||||
-57,022 | 57,827 | 57,968 | 43,817 | -28,797 | ||